
About BioQual
BioQual is a publicly listed company based in Rockville (United States) founded in 1981 by John Landon. Contract research on infectious disease models is conducted. BioQual has completed 1 acquisition, including ABL. BioQual offers products and services including In Vitro Services, Animal Models, and Research Solutions. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its legal entity is BIOQUAL, INC.
Company details
BioQual was founded in 1981 and is based in Rockville, United States, operating as a contract research organization in the biotechnology sector. Services are provided for in vivo models of human diseases such as AIDS, influenza, RSV, Zika, dengue, malaria, hepatitis, and cancer. Evaluations of vaccines, therapeutics, microbicides, and drug therapies are performed, alongside in vitro assessments of immunologic, virologic, and molecular parameters including sample processing and virus neutralization assays.
- Headquarters Rockville, United States
- Founders John Landon
- Stage Public
- SectorsHealthcare
- Website bioqual.com
- Social LinkedIn X
- Legal Name Bioqual, Inc.
- Annual Revenue$39.95 M (USD)-18.25as on May 31, 2026
- Net Profit-$4.17 M (USD)-297.71as on May 31, 2026
- EBITDA-$2.25 M (USD)-575.62as on May 31, 2026
- Investments & Acquisitions
Products & Services of BioQual
BioQual offers a comprehensive portfolio of products and services, including In Vitro Services, Animal Models, and Research Solutions.
Offers cell-based assays and immunoassays for research support.
Provides small and large animals for preclinical disease studies.
Delivers tailored toxicology and assay development for clients.
People of BioQual
17 people are tracked at BioQual (8 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
John Landon | Founder | Leadership |
Hanne Andersen Elyard | President And CSO | Leadership |
Swagata Kar | Vice President Marketing | Leadership |
Mitchell Franklin | Chief Operating Officer | Leadership |
Mark G Lewis | President/CEO | Leadership |
Andrew Faudree | Facility Director And Operations Manager | Leadership |
Chris Kirk | Chief Financial Officer | Leadership |
Soumen Paul | Study Director | Leadership |
Michael Bertrand | Animal Behaviorist | Team |
Isaiah Glenn | Associate Operations Manager | Team |
MacIel Porto | Laboratory Supervisor | Team |
Rebecca Stone | Senior Research Associate | Team |
Tatyana Orekov | Research And Development | Team |
Estella Cox | Quality Assurance Manager | Team |
Sarah Benyamin | Contracts Pricing Analyst | Team |
David Belgorodsky | Research Associate I (pcr/qpcr) | Team |
Casey Gardner | Quality Assurance Specialist II | Team |
Complete people profiles for BioQual
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BioQual
BioQual is a publicly listed company on the OTC with ticker symbol BIOQ in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Jan 2000
- Listed onOTCMKTS: BIOQ
- Listed entityBIOQUAL, Inc.
- Exchange sectorFinance
- ISINUS09065J1016
- Share price$35.20 (-6.16% on the day) · 2026-05-11
- Market capitalisation$31.5M
- EPS (diluted, trailing year)$-1.38
- Volume (last session)100
- Analyst consensusNo rating
Financials of BioQual
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $40.0M | -$4.2M | -$2.2M |
| 2024 | $48.9M | -$1.1M | $473,970 |
| 2023 | $58.6M | $483,480 | $2.5M |
| 2022 | $62.7M | $835,550 | $6.9M |
| 2021 | $66.2M | $5.3M | $14.7M |
Detailed financial statements for BioQual
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioQual
BioQual has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ABL.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract research and manufacturing for biologics and vaccines are provided. | ablinc.com | Rockville, United States | 1961 | Feb 2014 | β’β’β’β’ |
Complete acquisition details for BioQual
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioQual
3 dated milestones of BioQual across 33 years, from founding to its latest funding, stage changes and deals.
- Founded BioQual is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ABL.
Web traffic of BioQual
The website of BioQual (bioqual.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 1.6% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as BioQual (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioqual
Complete news archive for BioQual
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioQual
BioQual was founded in 1981.
BioQual is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Annual revenue of BioQual is $39.95M as on May 31, 2026.
BioQual was founded in 1981 and is based in Rockville, United States, operating as a contract research organization in the biotechnology sector. Services are provided for in vivo models of human diseases such as AIDS, influenza, RSV, Zika, dengue, malaria, hepatitis, and cancer. Evaluations of vaccines, therapeutics, microbicides, and drug therapies are performed, alongside in vitro assessments of immunologic, virologic, and molecular parameters including sample processing and virus neutralization assays.
BioQual offers In Vitro Services, Animal Models, and Research Solutions.
Yes, BioQual is publicly traded on OTC under the ticker symbol BIOQ.
BioQual has made 1 acquisition, including ABL.
BioQual operates through Bioqual, Inc..
